James Michael Woolven
University of California, Berkeley
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James Michael Woolven.
Journal of Medicinal Chemistry | 2012
Chun-wa Chung; Anthony W. Dean; James Michael Woolven; Paul Bamborough
Bromodomain-containing proteins are key epigenetic regulators of gene transcription and readers of the histone code. However, the therapeutic benefits of modulating this target class are largely unexplored due to the lack of suitable chemical probes. This article describes the generation of lead molecules for the BET bromodomains through screening a fragment set chosen using structural insights and computational approaches. Analysis of 40 BRD2/fragment X-ray complexes highlights both shared and disparate interaction features that may be exploited for affinity and selectivity. Six representative crystal structures are then exemplified in detail. Two of the fragments are completely new bromodomain chemotypes, and three have never before been crystallized in a bromodomain, so our results significantly extend the limited public knowledge-base of crystallographic small molecule/bromodomain interactions. Certain fragments (including paracetamol) bind in a consistent mode to different bromodomains such as CREBBP, suggesting their potential to act as generic bromodomain templates. An important implication is that the bromodomains are not only a phylogenetic family but also a system in which chemical and structural knowledge of one bromodomain gives insights transferrable to others.
Journal of Medicinal Chemistry | 2008
Clive Yeates; John F. Batchelor; Edward C. Capon; Neil J. Cheesman; Mitch Fry; Alan Thomas Hudson; Mary Pudney; Helen Trimming; James Michael Woolven; José M. Bueno; Jesús Chicharro; Esther Fernández; Jose M. Fiandor; Domingo Gargallo-Viola; Federico Gómez de las Heras; Esperanza Herreros; María Luisa León
A series of diaryl ether substituted 4-pyridones have been identified as having potent antimalarial activity superior to that of chloroquine against Plasmodium falciparum in vitro and murine Plasmodium yoelii in vivo. These were derived from the anticoccidial drug clopidol through a systematic study of the effects of varying the side chain on activity. Relative to clopidol the most active compounds show >500-fold improvement in IC50 for inhibition of P. falciparum in vitro and about 100-fold improvement with respect to ED50 against P. yoelii in mice. These compounds have been shown elsewhere to act selectively by inhibition of mitochondrial electron transport at the cytochrome bc1 complex.
ACS Medicinal Chemistry Letters | 2013
Catherine Mary Alder; Martin Ambler; Amanda J. Campbell; Aurelie Cecile Champigny; Angela M. Deakin; John D. Harling; Carol A. Harris; Tim Longstaff; Sean Lynn; Aoife C. Maxwell; Chris J. Mooney; Callum Scullion; Onkar M. P. Singh; Ian Edward David Smith; Donald O. Somers; Christopher J. Tame; Gareth Wayne; Caroline Wilson; James Michael Woolven
Inhibition of Itk potentially constitutes a novel, nonsteroidal treatment for asthma and other T-cell mediated diseases. In-house kinase cross-screening resulted in the identification of an aminopyrazole-based series of Itk inhibitors. Initial work on this series highlighted selectivity issues with several other kinases, particularly AurA and AurB. A template-hopping strategy was used to identify a series of aminobenzothiazole Itk inhibitors, which utilized an inherently more selective hinge binding motif. Crystallography and modeling were used to rationalize the observed selectivity. Initial exploration of the SAR around this series identified potent Itk inhibitors in both enzyme and cellular assays.
Current Topics in Medicinal Chemistry | 2017
Alan P. Graves; Ian D. Wall; Colin M. Edge; James Michael Woolven; Guanglei Cui; Armelle Le Gall; Xuan Hong; Kaushik Raha; Eric S. Manas
Over the last decade, a number of computational methods have been developed, which attempt to evaluate the thermodynamic properties of individual water molecules at the solute-solvent interface, in order to assess contributions to protein-ligand binding. In some cases, these tools tell us what we already know, e.g. that hydrophobic pockets prefer lipophilic substituents, and in other cases the methods only seem to add clarity when retrospectively applied. Hence we have grappled with how to utilize such approaches to understand non-intuitive results and to generate chemistry ideas that otherwise would not have been developed. Here we provide our perspective on these methods and describe how results have been interpreted and applied. We include examples from GSK and elsewhere that highlight how water methods have been (1) utilized retrospectively to explain non-intuitive structure- activity relationships and (2) applied prospectively for chemistry design. Finally, we discuss where this field of study could lead to maximal impact in drug discovery research.
Journal of Medicinal Chemistry | 2006
Gregory L. Warren; C. Webster Andrews; Anna-Maria Capelli; B Clarke; Judith M. LaLonde; Millard H. Lambert; Mika Lindvall; Neysa Nevins; Simon F. Semus; Stefan Senger; Giovanna Tedesco; Ian D. Wall; James Michael Woolven; Catherine E. Peishoff; Martha S. Head
Journal of Medicinal Chemistry | 2004
Francoise Jeanne Gellibert; James Michael Woolven; Marie-Hélène Fouchet; Neil Mathews; Helen Goodland; Victoria Lovegrove; Alain Laroze; Van-Loc Nguyen; Stéphane Sautet; Ruolan Wang; Cheryl A. Janson; Ward W. Smith; Gael Krysa; Valerie Boullay; Anne‐Charlotte le Monnier de Gouville; and Stéphane Huet; David Hartley
Journal of Medicinal Chemistry | 2006
Francoise Jeanne Gellibert; Anne‐Charlotte le Monnier de Gouville; James Michael Woolven; Neil Mathews; Van-Loc Nguyen; Cécile Bertho-Ruault; Angela Patikis; Eugene T. Grygielko; Nicholas J. Laping; Stephane Huet
Journal of Medicinal Chemistry | 2002
Alan D. Borthwick; Andrew James Crame; Peter Ertl; Anne M. Exall; Terry M. Haley; Graham J. Hart; Andrew Mcmurtrie Mason; Andrew M. K. Pennell; Onkar M. P. Singh; Gordon G. Weingarten; James Michael Woolven
Journal of Medicinal Chemistry | 2003
Alan D. Borthwick; Dave E. Davies; Peter Ertl; Anne M. Exall; Terry M. Haley; Graham J. Hart; Deborah L. Jackson; Nigel R. Parry; Angela Patikis; Naimisha Trivedi; Gordon G. Weingarten; James Michael Woolven
Archive | 2002
Francoise Jeanne Gellibert; Charles David Hartley; Neil Mathews; James Michael Woolven